GREY:ATBPF - Post by User
Post by
IrishCanuckon Nov 26, 2020 3:16pm
835 Views
Post# 31982742
If...
If...Dan sounds so confident in the meeting about uplisting to a major index (NASDAQ) and partnering. This is an idea (speculation) equally as invalid as others:
Do you think there would be a partnering/bought deal to issue more shares after the reverse split, but at such a higher price that it funds Phase 3 and brings each share value up 2-3x fold?
ex. 200 million USD for 20 million shares = $10 USD per share for 1/3 equity in the company. Antibe clearly hits NASDAQ listing requirements, Antibe hits $600 million market cap entering Phase 3, half the funding goes toward developing other drugs in the pipeline and half goes toward Otenaproxesul